Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-28053515

ABSTRACT

T lymphocytes are believed to play an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). How T cells are recruited to the lungs and contribute to the inflammatory process is largely unknown. COPD is a heterogeneous disease, and discriminating disease phenotypes based on distinct molecular and cellular pathways may provide new approaches for individualized diagnosis and therapies. Bronchoalveolar lavage (BAL) and blood samples were obtained from 40 never-smokers, 40 smokers with normal lung function, and 38 COPD patients. T-cell chemokine receptor expression was analyzed with flow cytometry, and soluble BAL cytokines and chemokines were measured using a cytokine multiplex assay. Correlations with gender and clinical characteristics including lung imaging were investigated using multivariate modeling. Th1/Tc1- and Th2/Tc2-associated soluble analytes and T-cell chemokine receptors were analyzed as cumulative Th1/Tc1 and Th2/Tc2 immune responses. A higher expression of chemokine receptor CCR5 on CD8+ T cells in BAL and higher percentage of CXCR3+CD8+ T cells in blood was found in female smokers with COPD compared to those without COPD. CCR5 expression on CD4+ and CD8+ T cells was lower in BAL from male smokers with COPD compared to those without COPD. Among female smokers with COPD, Th1/Tc1 immune response was linked to BAL macrophage numbers and goblet cell density, and Th2/Tc2 response was associated with the measures of emphysema on high-resolution computed tomography. The highly gender-dependent T-cell profile in COPD indicates different links between cellular events and clinical manifestations in females compared to males. Our findings may reveal mechanisms of importance for the difference in clinical course in female COPD patients compared to males.


Subject(s)
Health Status Disparities , Lung/immunology , Pulmonary Disease, Chronic Obstructive/immunology , T-Lymphocyte Subsets/immunology , Adult , Aged , Biomarkers/analysis , Bronchoalveolar Lavage Fluid/immunology , Case-Control Studies , Cytokines/analysis , Female , Humans , Inflammation Mediators/analysis , Lung/physiopathology , Male , Middle Aged , Phenotype , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/physiopathology , Receptors, Chemokine/analysis , Risk Factors , Sex Factors , Smoking/adverse effects , Smoking/immunology , Th1-Th2 Balance
2.
Clin Immunol ; 169: 114-120, 2016 08.
Article in English | MEDLINE | ID: mdl-27339331

ABSTRACT

Cigarette smoking is a risk factor for multiple sclerosis (MS), and the risk is further multiplied for HLA-DRB1*15(+) smokers. To define the smoke-induced immune responses in the lung we performed bronchoscopy with bronchoalveolar lavage (BAL) on smokers and non-smokers, both MS-patients and healthy volunteers. In the BAL, non-smokers with MS showed an increased preformed CD40L expression in CD4(+) T-cells while smokers displayed an increase in proliferating (Ki-67(+)) T-cells. In addition, our results confirm that smoking induces an increase of alveolar macrophages in BAL, and further defined a significant attenuation of this response in carriers of the HLA-DRB1*15 allele, in both MS patients and healthy controls. This first systematic investigation of the immune response in the lungs of smokers and non-smokers diagnosed with MS, thus suggests an MS-associated lung T-cell phenotype, involvement of a specific T-cell response to smoke, and a genetic regulation of the macrophage response.


Subject(s)
HLA-DRB1 Chains/immunology , Lung/immunology , Multiple Sclerosis/immunology , Smoking/immunology , T-Lymphocytes/immunology , Adult , Alleles , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Bronchoscopy , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , CD40 Ligand/immunology , CD40 Ligand/metabolism , Female , Flow Cytometry , HLA-DRB1 Chains/genetics , Humans , Ki-67 Antigen/immunology , Ki-67 Antigen/metabolism , Linear Models , Lung/metabolism , Lung/physiopathology , Lymphocyte Activation/immunology , Macrophages, Alveolar/immunology , Macrophages, Alveolar/metabolism , Male , Middle Aged , Multiple Sclerosis/genetics , Multiple Sclerosis/metabolism , Risk Factors , Smoking/genetics , T-Lymphocytes/metabolism , Young Adult
3.
Proteins ; 65(2): 266-73, 2006 Nov 01.
Article in English | MEDLINE | ID: mdl-16948159

ABSTRACT

The implementation of generic and efficient technologies for the production of recombinant eukaryotic proteins remains an outstanding challenge in structural genomics programs. We have recently developed a new method for rapid identification of soluble protein expression in E. coli, the colony filtration blot (CoFi blot). In this study, the CoFi blot was used to screen libraries where the N-terminal translation start point was randomized. To investigate the efficiency of this strategy, we have attributed a large number of proteins to this process. In a set of 32 mammalian proteins, we were able to double the success rate (from 34 to 68%) of producing soluble and readily purifiable proteins in E. coli. Most of the selected constructs had their N-termini close to predicted domain borders and the method therefore provides a mean for experimental "domain foot printing." Surprisingly, for most of the targets, we also observed expressing constructs that were close to full-length. In summary this strategy constitutes a generic and efficient method for producing mammalian proteins for structural and functional studies.


Subject(s)
Escherichia coli/metabolism , Gene Library , Recombinant Proteins/metabolism , Cloning, Molecular , Escherichia coli/genetics , Humans , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Solubility
4.
Acta Crystallogr D Biol Crystallogr ; 60(Pt 4): 775-6, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15039583

ABSTRACT

Pseudouridine, the 5-ribosyl isomer of uridine, is the most common modification of structural RNA. The recently identified pseudouridine synthase TruD belongs to a widespread class of pseudouridine synthases without significant sequence homology to previously known families. TruD from Escherichia coli was overexpressed, purified and crystallized. The crystals diffract to a minimum Bragg spacing of 2.4 A and belong to space group P2(1)2(1)2(1), with unit-cell parameters a = 63.4, b = 108.6, c = 111.7 A.


Subject(s)
Crystallization , Escherichia coli Proteins/chemistry , Intramolecular Transferases/chemistry , Cloning, Molecular , Crystallography, X-Ray , Hydro-Lyases/chemistry
5.
Neuroreport ; 13(15): 1857-60, 2002 Oct 28.
Article in English | MEDLINE | ID: mdl-12395079

ABSTRACT

The Arctic amyloid precursor protein (APP) Alzheimer mutation, is located inside the beta-amyloid (Abeta) domain. Here, hybrid APP mutants containing both the Swedish and the Arctic APP mutations were investigated. ELISA measurements of cell media showed decreased levels of both Abeta40 and Abeta42. Similar results were obtained for the Dutch and Italian mutations, whereas the Flemish mutation displayed increased amounts of Abeta40 and Abeta42. Immunoprecipitation studies revealed increased Abeta40/p3 and Abeta42/p3 ratios for the Arctic mutation. These results were further verified by quantification revealing decreased levels of alphaAPPs accompanied by increased betaAPPs levels in the media. Thus, the pathogenic effects of the Arctic mutation may not only be due to the changed properties of the peptide but also altered processing of Arctic APP.


Subject(s)
Alzheimer Disease/genetics , Amyloid beta-Peptides/genetics , Amyloid beta-Protein Precursor/genetics , Brain Chemistry/genetics , Brain/metabolism , Mutation/genetics , Peptide Fragments/genetics , Alzheimer Disease/metabolism , Amyloid Precursor Protein Secretases , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/metabolism , Arctic Regions , Aspartic Acid Endopeptidases/genetics , Aspartic Acid Endopeptidases/metabolism , Brain/physiopathology , Cells, Cultured , Culture Media/metabolism , Down-Regulation/genetics , Endopeptidases/genetics , Endopeptidases/metabolism , Gene Expression Regulation/genetics , Humans , Peptide Fragments/metabolism , Up-Regulation/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...